ADVANZ PHARMA Corp. Limited
ADVANZ PHARMA Corp. Limited, headquartered in Great Britain, is a prominent player in the pharmaceutical industry, specialising in the development and commercialisation of specialty and generic medicines. Founded in 2018, the company has rapidly established itself across key operational regions, including Europe and North America, focusing on therapeutic areas such as oncology, neurology, and infectious diseases. With a commitment to providing high-quality, accessible healthcare solutions, ADVANZ PHARMA offers a diverse portfolio of products that stand out for their efficacy and safety. The company has achieved significant milestones, including strategic partnerships and a growing market presence, positioning itself as a trusted provider in the pharmaceutical landscape. Through innovation and a patient-centric approach, ADVANZ PHARMA continues to enhance its reputation and impact within the healthcare sector.
DitchCarbon Score
How does ADVANZ PHARMA Corp. Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ADVANZ PHARMA Corp. Limited's score of 16 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ADVANZ PHARMA Corp. Limited's reported carbon emissions
ADVANZ PHARMA Corp. Limited, headquartered in Great Britain, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, ADVANZ PHARMA's climate commitments and initiatives remain unclear, and there is no inherited emissions data from a parent or related organization. The company has not established any Science-Based Targets Initiative (SBTi) reduction targets or other significant climate initiatives at this time. In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction strategies, but ADVANZ PHARMA has yet to publicly commit to such measures.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ADVANZ PHARMA Corp. Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
